Ambu A/S (OTCMKTS:AMBBY – Get Free Report) announced a dividend on Tuesday, November 5th, NASDAQ reports. Shareholders of record on Friday, December 6th will be given a dividend of 0.0557 per share on Monday, December 23rd. The ex-dividend date is Friday, December 6th.
Ambu A/S Price Performance
Shares of AMBBY traded down $1.31 during midday trading on Wednesday, hitting $17.44. The company’s stock had a trading volume of 148 shares, compared to its average volume of 711. The company has a quick ratio of 1.51, a current ratio of 2.52 and a debt-to-equity ratio of 0.09. Ambu A/S has a one year low of $12.65 and a one year high of $22.65. The stock has a market capitalization of $4.10 billion and a price-to-earnings ratio of 78.14. The company’s fifty day simple moving average is $19.11 and its two-hundred day simple moving average is $19.06.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last released its earnings results on Friday, August 30th. The company reported $0.07 earnings per share (EPS) for the quarter. The firm had revenue of $199.56 million for the quarter. Ambu A/S had a return on equity of 8.09% and a net margin of 8.55%.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Further Reading
- Five stocks we like better than Ambu A/S
- 3 REITs to Buy and Hold for the Long Term
- What a Trump Win Looks Like for the Market Now and Into 2025
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.